Echo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $7,636,443.
Profit Margin
| 2012 | 5.11K | -12.33M | -240906.58% |
|---|---|---|---|
| 2013 | 27.6K | -19.06M | -69084.77% |
| 2014 | 57.32K | -14.96M | -26103.27% |
| 2015 | 0 | -22.19M |
ECTE Income Statement (2012 – 2015)
| 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 57.32K | 27.6K | 5.11K |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 57.32K | 27.6K | 5.11K |
Operating exp. | ||||
Research and development | 2.78M | 4.96M | 11.29M | 8.67M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 7.63M | 12.37M | 19.66M | 15.04M |
Operating income | -7.63M | -12.31M | -19.63M | -15.04M |
Other income (expenses), net | -14.55M | -2.63M | 569.07K | 2.70M |
Income before tax | -22.19M | -14.95M | -19.06M | -12.33M |
Income tax expense | 3.42K | 4K | 4.46M | 0 |
Net income | -22.19M | -14.96M | -19.06M | -12.33M |
Earnings per share | ||||
Basic EPS | -1.98 | -1.22 | -2.28 | -3.1 |
Diluted EPS | -1.98 | -1.22 | -2.28 | -3.1 |
| Data source | Data source | Data source | Data source |